Jivan Expands Business Focus to PCR, Software,
Arrays for Alternative Splicing

(June 17, 2008) – Jivan Biologics, Inc. announced today that the company has expanded its focus to encompass multiple technologies for high-throughput alternative splicing analysis: PCR, microarrays, software and databases. In 2001 Jivan began with a focus on microarray services for alternative splicing -- the industry's first. As Jivan further developed the technology, Jivan subsequently launched the first catalog splice array, the first genome-wide splicing array, the first genome-wide PCR primer set for splice isoform detection, and the first software package designed for analyzing splicing data. Jivan believes these developments represent significant market opportunities, individually and together.

Jivan intends to broaden its focus to a complete range of products for high-throughput analysis of alternative RNA splicing, which may improve the next generation of drugs, biomarkers, diagnostics and medical research. The new focus is conveyed in Jivan's updated tag line, "Solutions for Alternative Splicing".

Jivan Biologics empowers scientists with new insight by providing a full catalogue of splice variant microarrays, analysis software and PCR primer designs to benefit all stages of the drug development pipeline: biomarkers in blood, diagnostics, target validation, toxicology and basic research.